A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405.
Publication
, Conference
Innocenti, F; Owzar, K; Jiang, C; Sibley, A; Niedzwiecki, D; Lenz, H-J; Bertagnolli, MM; Friedman, PN; Furukawa, Y; Kubo, M; Ratain, MJ ...
Published in: Journal of Clinical Oncology
May 20, 2015
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2015
Volume
33
Issue
15_suppl
Start / End Page
3599 / 3599
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Innocenti, F., Owzar, K., Jiang, C., Sibley, A., Niedzwiecki, D., Lenz, H.-J., … McLeod, H. L. (2015). A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405. In Journal of Clinical Oncology (Vol. 33, pp. 3599–3599). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.3599
Innocenti, Federico, Kouros Owzar, Chen Jiang, Alexander Sibley, Donna Niedzwiecki, Heinz-Josef Lenz, Monica M. Bertagnolli, et al. “A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405.” In Journal of Clinical Oncology, 33:3599–3599. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3599.
Innocenti F, Owzar K, Jiang C, Sibley A, Niedzwiecki D, Lenz H-J, et al. A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3599–3599.
Innocenti, Federico, et al. “A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 3599–3599. Crossref, doi:10.1200/jco.2015.33.15_suppl.3599.
Innocenti F, Owzar K, Jiang C, Sibley A, Niedzwiecki D, Lenz H-J, Bertagnolli MM, Friedman PN, Furukawa Y, Kubo M, Ratain MJ, Blanke CD, Venook AP, McLeod HL. A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3599–3599.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2015
Volume
33
Issue
15_suppl
Start / End Page
3599 / 3599
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences